4-{[(3S)-2-(4-Chloro-2-{4-[(5-Cyano-1,2-Dimethyl-1H-Pyrrol-3-Yl)(4-Hydroxyphenyl)Carbamoyl]-1,5-Dimethyl-1H-Pyrrol-2-Yl}Benzoyl)-1,2,3,4-Tetrahydroisoquinolin-3-Yl]Methyl}Morpholin-4-Ium Hydrogen Sulfate

1 trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

2 Countries

Phase I (FiH)

Phase I (FiH): 1

Sponsors using this IMP

1 total

Phase I/II trial of S65487 plus azacitidine in acute myeloid leukemia Ended

2023-510051-27-00 Phase I (FiH) 2 countries Institut De Recherches Internationales Servier IRIS

Showing 1–1 of 1 trials